These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19823014)

  • 21. Pancreatic Cancer Therapy Review: From Classic Therapeutic Agents to Modern Nanotechnologies.
    Rebelo A; Molpeceres J; Rijo P; Reis CP
    Curr Drug Metab; 2017; 18(4):346-359. PubMed ID: 28155623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells.
    Sundaramoorthy P; Ramasamy T; Mishra SK; Jeong KY; Yong CS; Kim JO; Kim HM
    Acta Biomater; 2016 Sep; 42():220-231. PubMed ID: 27395829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Nanotechnology-An Excursion on Drug Delivery Systems.
    Sharma M; Pandey C; Sharma N; Kamal MA; Sayeed U; Akhtar S
    Anticancer Agents Med Chem; 2018; 18(15):2078-2092. PubMed ID: 30033877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of nanomedical approaches in experimental and clinical oncology.
    Torchilin VP
    Anticancer Agents Med Chem; 2006 Nov; 6(6):501. PubMed ID: 17100554
    [No Abstract]   [Full Text] [Related]  

  • 25. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer.
    Parker JP; Ude Z; Marmion CJ
    Metallomics; 2016 Jan; 8(1):43-60. PubMed ID: 26567482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances toward More Efficient Targeted Delivery of Nanoparticles in Vivo: Understanding Interactions between Nanoparticles and Cells.
    Polo E; Collado M; Pelaz B; Del Pino P
    ACS Nano; 2017 Mar; 11(3):2397-2402. PubMed ID: 28267316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymoquinone-based nanotechnology for cancer therapy: promises and challenges.
    Ballout F; Habli Z; Rahal ON; Fatfat M; Gali-Muhtasib H
    Drug Discov Today; 2018 May; 23(5):1089-1098. PubMed ID: 29374534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovative nano-carriers in anticancer drug delivery-a comprehensive review.
    Dong P; Rakesh KP; Manukumar HM; Mohammed YHE; Karthik CS; Sumathi S; Mallu P; Qin HL
    Bioorg Chem; 2019 Apr; 85():325-336. PubMed ID: 30658232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
    Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
    Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR 20th Anniversary Commentary: Prospects and Challenges of Therapeutic Nanoparticles in Cancer.
    Rahman MA; Shin DM
    Clin Cancer Res; 2015 Oct; 21(20):4499-501. PubMed ID: 26473185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle-Based Drug Delivery Systems for Enhanced Tumor-Targeting Treatment.
    Li Y; Zhang H
    J Biomed Nanotechnol; 2019 Jan; 15(1):1-27. PubMed ID: 30480512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
    Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
    Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
    Parhi P; Mohanty C; Sahoo SK
    Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress in nanotechnology for cancer therapy.
    Tang MF; Lei L; Guo SR; Huang WL
    Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.